The benefits of establishing an in-depth go-to-market commercialization strategy for a new CGT in the beginning of clinical trials
Ben Beckley, EmerGENE
Advertisement
Articles by Ben Beckley, EmerGENE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cencora-Kite Agreement Signals CGT Commercialization Shift
2
Q&A: Dr. Reddy's CEO on Generic Semaglutide and the GLP-1 Market Ahead
3
Wegovy Pill's UAE Debut Is a Distribution Story, Not Just a Market Entry
4
A Biopharma Perspective on What’s Next in Access & Affordability
5